Key facts
- Agragene’s last known valuation is $16.0M (Feb 2021).
- It has raised $12.4M; the latest was Accelerator/Incubator in Apr 2026.
- Notable investors include CONNECT (San Diego), BioGenerator Ventures, Missouri Technology Corporation, Ospraie Ag Science(farming), Fresh Field Catalyst Accelerator — 6 tracked in total.
- 2 investment vehicles were formed to buy Agragene shares in the last 12 months, reporting $312K sold to 12 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Agragene
- ·The full record, as it builds
Funding rounds
No funding rounds for Agragene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 2 investment vehicles were formed to buy Agragene shares, reporting $312K sold to 12 investors across 2 sponsors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Agragene
Developer of precision-guided sterile insect technology designed to offer effective biological crop pest control, pesticide, chemical, and radiation-free. The company uses precision-guided sterile insects to create and commercialize sustainable products that apply to thousands of insect pests worldwide, and also commercially deploys the trap insect detection system, enabling farmers to enhance the quality and productivity of economically important foods and crops.
- Sector
- Materials and Resources
- HQ
- Saint Louis, MO, United States
- Founded
- 2017
- Employees
- 12
- Website
- agragene.com/
- Ownership
- Privately Held (backing)
Agragene doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Agragene shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Agragene in its N-PORT filings yet. We sweep new filings monthly.